Free-cash-flow proxy increased 67.5%
Free-cash-flow proxy changed +67.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
-$80.1M→-$26.0M4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →AUTL financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating cash flow increased 65.6%
Operating cash flow changed +65.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
-$72.8M→-$25.1M4 prior comparisons
Operating income increased 28.4%
Operating income changed +28.4% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
-$61.2M→-$43.8M3 prior comparisons
Working capital / assets moved 1600 bp lower
Working capital / assets changed -1600 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
70.20%→54.19%4 prior comparisons
Operating margin moved 19663 bp higher
Operating margin changed +19663 basis points from the comparable as-filed period.
-292.58%→-95.95%2 prior comparisons
Cash & equivalents increased 38.4%
Cash & equivalents changed +38.4% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$123.8M→$171.4M3 prior comparisons
Revenue increased 118.4%
Revenue changed +118.4% from the comparable as-filed period.
$20.9M→$45.7M2 prior comparisons
Capex / revenue moved 3278 bp lower
Capex / revenue changed -3278 basis points from the comparable as-filed period.
34.78%→2.00%2 prior comparisons
Capital expenditure decreased 87.5%
Capital expenditure changed -87.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$7.3M→$913,0004 prior comparisons
Current assets decreased 41.5%
Current assets changed -41.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$574.3M→$336.1M4 prior comparisons
Inventory / revenue moved 4126 bp lower
Inventory / revenue changed -4126 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
114.43%→73.17%2 prior comparisons
Inventory increased 39.6%
Inventory changed +39.6% from the comparable as-filed period.
$23.9M→$33.4M2 prior comparisons
Selling, general & administrative increased 36.0%
Selling, general & administrative changed +36.0% from the comparable as-filed period.
$30.3M→$41.2M2 prior comparisons
Total assets decreased 31.6%
Total assets changed -31.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$721.0M→$493.2M4 prior comparisons
Working capital decreased 47.2%
Working capital changed -47.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$506.1M→$267.3M4 prior comparisons
SBC / revenue moved 1046 bp lower
SBC / revenue changed -1046 basis points from the comparable as-filed period.
20.52%→10.06%2 prior comparisons
Current ratio decreased 42.0%
Current ratio changed -42.0% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
8.43→4.894 prior comparisons
Free-cash-flow margin moved 32576 bp higher
Free-cash-flow margin changed +32576 basis points from the comparable as-filed period.
-382.63%→-56.87%2 prior comparisons
Operating cash-flow margin moved 29298 bp higher
Operating cash-flow margin changed +29298 basis points from the comparable as-filed period.
-347.85%→-54.87%2 prior comparisons
R&D / revenue moved 7004 bp lower
R&D / revenue changed -7004 basis points from the comparable as-filed period.
131.10%→61.06%2 prior comparisons
Shares outstanding increased 0.0%
Shares outstanding changed +0.0% from the comparable as-filed period. The change ranks at the 29th percentile of 7 prior comparable changes.
266,141,411→266,162,5407 prior comparisons
Research & development increased 1.7%
Research & development changed +1.7% from the comparable as-filed period.
$27.4M→$27.9M3 prior comparisons
Stock-based compensation increased 7.0%
Stock-based compensation changed +7.0% from the comparable as-filed period.
$4.3M→$4.6M3 prior comparisons
Current liabilities increased 0.9%
Current liabilities changed +0.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$68.2M→$68.8M4 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.